Before starting
Required
- Baseline
- Liver function testsIf hepatotoxicity suspected or extended treatment anticipated
- Serum creatinine (for creatinine clearance) or Estimated glomerular filtration rateIf renal impairment suspected or extended treatment anticipated
Ongoing once stable
Required if treatment longer than 6 months
- Every 3 months
- Liver function testsMay cause hepatitis
- Pigmentation
- Systemic lupus erythematosus
Consider if treatment longer than 6 months
- Every 3 months
- Full blood count
- Serum creatinine (for creatinine clearance) or Estimated glomerular filtration rateMay cause acute kidney injury
Abnormal results
Respond to patient symptoms and conditions
Stop minocycline if any of the following develop:
- hepatotoxicity
- unusual pigmentation
- systemic lupus erythematosus (SLE) or lupus-like or serum sickness-like syndromes or pre-existing SLE gets worse
- raised intracranial pressure
- hypersensitivity syndrome consisting of cutaneous reaction (such as rash or exfoliative dermatitis), eosinophilia and one or more of:
- hepatitis
- pneumonitis
- nephritis
- myocarditis
- pericarditis
- fever and lymphadenopathy
Respond to absolute values
Full blood count
Stop minocycline and contact specialist if eosinophil count more than upper limit of normal
Notes
Less suitable for prescribing
Minocycline is not recommended for use in acne as it is associated with an increased risk of drug-induced lupus, skin pigmentation and hepatitis.
Bibliography
- British National Formulary (online) London: BMJ Group and Pharmaceutical Press [cited 04/06/2026]
- Bechman K, Song K, Abhishek Aet al. , The 2025 British Society for Rheumatology guideline for the prescription and monitoring of conventional synthetic disease-modifying anti-rheumatic drugs , Rheumatology, Volume 65, Issue 2, February 2026,Pages 1-36[cited 04/06/2026]
- Acnamino MR100mg Capsules. Acnamino MR 100mg Capsules – Summary of Product Characteristics (SmPC) – (emc) | 654 Last revised 25/03/2026 [cited 04/06/2026]
- NHS England. Items which should not routinely be prescribed in primary care: policy guidance: Published August 2023, updated July 2025 [cited 04/06/2026]
- NICE Clinical Knowledge Summaries (CKS). Acne Vulgaris: Scenario: management of acne vulgaris in primary care. Updated February 2026 [cited 04/06/2026]
Update history
- Full update and review. New sections added 'Required if treatment longer than 6 months' and 'Less suitable for prescribing'
- Republished
- Published